Editor-in-chief's viewpoint - DiabetesontheNet

Editor-in-chief’s viewpoint: Personal and practical aspects of diabetes medicines and devices

Editor’s viewpoint: Social networking with the lost tribe of diabetes

Editor’s viewpoint: The boy done well

Editor’s viewpoint: Alcohol industry neither shaken nor stirred by self-regulation

Editor’s viewpoint: Googled yourself lately? Your patients probably have

Editor’s viewpoint: Deus ex machina

Editor’s viewpoint: The rocky, yet unremarkable road of media hype

Editor’s viewpoint: Addressing the imbalance of international diabetes care

Editor’s viewpoint: Fiscal failures and corporate controversy

Editor’s viewpoint: Every little helps…

Editor’s viewpoint: The “tomato effect”

Editor’s viewpoint: The forgotten few

Editor’s viewpoint: All change at the top

Editor’s viewpoint: Laying the foundations of a QOF for specialist diabetes care

Editor’s viewpoint: Insulin initiation in type 2 diabetes. More science than art

Editor’s viewpoint: A socialist, capitalist or pipe-and-slippers approach to diabetes research?

Editor’s viewpoint: Who’s taking what and is it the real thing?

Editor’s viewpoint: More emphasis on the first two Rs, less on the third please!